H&R GMBH & CO KGAA (2HRA.DE) Stock Fundamental Analysis
FRA:2HRA - Deutsche Boerse Ag - DE000A2E4T77 - Common Stock - Currency: EUR
Overall 2HRA gets a fundamental rating of 4 out of 10. We evaluated 2HRA against 61 industry peers in the Chemicals industry. 2HRA has only an average score on both its financial health and profitability. 2HRA has a valuation in line with the averages, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
2HRA had positive earnings in the past year.
In the past year 2HRA had a positive cash flow from operations.
Of the past 5 years 2HRA 4 years were profitable.
2HRA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
2HRA has a Return On Assets of 0.59%. This is comparable to the rest of the industry: 2HRA outperforms 50.82% of its industry peers.
2HRA has a Return On Equity (1.31%) which is in line with its industry peers.
2HRA's Return On Invested Capital of 2.58% is in line compared to the rest of the industry. 2HRA outperforms 55.74% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 2HRA is in line with the industry average of 6.81%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.31% | ||
| ROIC | 2.58% |
ROA(3y)3.78%
ROA(5y)1.99%
ROE(3y)8.83%
ROE(5y)4.62%
ROIC(3y)6.18%
ROIC(5y)4.04%
1.3 Margins
2HRA has a Profit Margin of 0.42%. This is comparable to the rest of the industry: 2HRA outperforms 50.82% of its industry peers.
In the last couple of years the Profit Margin of 2HRA has declined.
2HRA has a Operating Margin (2.03%) which is in line with its industry peers.
In the last couple of years the Operating Margin of 2HRA has declined.
2HRA has a Gross Margin (23.12%) which is comparable to the rest of the industry.
2HRA's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.03% | ||
| PM (TTM) | 0.42% | ||
| GM | 23.12% |
OM growth 3Y62.81%
OM growth 5Y-5.94%
PM growth 3YN/A
PM growth 5Y-16.63%
GM growth 3Y-3.05%
GM growth 5Y0%
2. Health
2.1 Basic Checks
2HRA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 2HRA remains at a similar level compared to 1 year ago.
2HRA has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for 2HRA has been reduced compared to a year ago.
2.2 Solvency
2HRA has an Altman-Z score of 2.32. This is not the best score and indicates that 2HRA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of 2HRA (2.32) is comparable to the rest of the industry.
2HRA has a debt to FCF ratio of 7.39. This is a slightly negative value and a sign of low solvency as 2HRA would need 7.39 years to pay back of all of its debts.
2HRA has a Debt to FCF ratio of 7.39. This is in the better half of the industry: 2HRA outperforms 65.57% of its industry peers.
2HRA has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
2HRA has a Debt to Equity ratio of 0.21. This is in the better half of the industry: 2HRA outperforms 75.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 7.39 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.47
WACC5.45%
2.3 Liquidity
A Current Ratio of 1.69 indicates that 2HRA should not have too much problems paying its short term obligations.
2HRA has a Current ratio (1.69) which is comparable to the rest of the industry.
2HRA has a Quick Ratio of 1.69. This is a bad value and indicates that 2HRA is not financially healthy enough and could expect problems in meeting its short term obligations.
2HRA has a Quick ratio (0.97) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.69 | ||
| Quick Ratio | 0.97 |
3. Growth
3.1 Past
2HRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -60.76%.
Measured over the past years, 2HRA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.49% on average per year.
2HRA shows a decrease in Revenue. In the last year, the revenue decreased by -4.27%.
2HRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.95% yearly.
EPS 1Y (TTM)-60.76%
EPS 3YN/A
EPS 5Y-13.49%
EPS Q2Q%-55%
Revenue 1Y (TTM)-4.27%
Revenue growth 3Y15.7%
Revenue growth 5Y3.95%
Sales Q2Q%0.24%
3.2 Future
2HRA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.73% yearly.
Based on estimates for the next years, 2HRA will show a decrease in Revenue. The Revenue will decrease by -0.53% on average per year.
EPS Next Y-46.59%
EPS Next 2Y-15.16%
EPS Next 3Y1.74%
EPS Next 5Y2.73%
Revenue Next Year-6.53%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.53%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.64, the valuation of 2HRA can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 2HRA is on the same level as its industry peers.
2HRA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.79.
The Price/Forward Earnings ratio is 12.85, which indicates a correct valuation of 2HRA.
Based on the Price/Forward Earnings ratio, 2HRA is valued cheaper than 80.33% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of 2HRA to the average of the S&P500 Index (21.38), we can say 2HRA is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.64 | ||
| Fwd PE | 12.85 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 2HRA is valued cheaper than 100.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of 2HRA indicates a rather cheap valuation: 2HRA is cheaper than 93.44% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.13 | ||
| EV/EBITDA | 2.22 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.16%
EPS Next 3Y1.74%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.50%, 2HRA has a reasonable but not impressive dividend return.
2HRA's Dividend Yield is comparable with the industry average which is at 3.19.
Compared to an average S&P500 Dividend Yield of 2.47, 2HRA has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
67.35% of the earnings are spent on dividend by 2HRA. This is not a sustainable payout ratio.
DP67.35%
EPS Next 2Y-15.16%
EPS Next 3Y1.74%
FRA:2HRA (4/25/2025, 7:00:00 PM)
4.15
+0.15 (+3.75%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners1.39%
Inst Owner ChangeN/A
Ins Owners6.06%
Ins Owner ChangeN/A
Market Cap154.46M
Analysts80
Price Target4.01 (-3.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.5% |
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DP67.35%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)17.5%
EPS NY rev (3m)-38.56%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.64 | ||
| Fwd PE | 12.85 | ||
| P/S | 0.12 | ||
| P/FCF | 7.13 | ||
| P/OCF | 2.17 | ||
| P/B | 0.37 | ||
| P/tB | 0.39 | ||
| EV/EBITDA | 2.22 |
EPS(TTM)0.14
EY3.37%
EPS(NY)0.32
Fwd EY7.78%
FCF(TTM)0.58
FCFY14.02%
OCF(TTM)1.91
OCFY46.08%
SpS35.71
BVpS11.31
TBVpS10.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.59% | ||
| ROE | 1.31% | ||
| ROCE | 4% | ||
| ROIC | 2.58% | ||
| ROICexc | 2.99% | ||
| ROICexgc | 3.14% | ||
| OM | 2.03% | ||
| PM (TTM) | 0.42% | ||
| GM | 23.12% | ||
| FCFM | 1.63% |
ROA(3y)3.78%
ROA(5y)1.99%
ROE(3y)8.83%
ROE(5y)4.62%
ROIC(3y)6.18%
ROIC(5y)4.04%
ROICexc(3y)6.77%
ROICexc(5y)4.47%
ROICexgc(3y)7.16%
ROICexgc(5y)4.74%
ROCE(3y)9.55%
ROCE(5y)6.25%
ROICexcg growth 3Y66.93%
ROICexcg growth 5Y-6.83%
ROICexc growth 3Y68.14%
ROICexc growth 5Y-6.27%
OM growth 3Y62.81%
OM growth 5Y-5.94%
PM growth 3YN/A
PM growth 5Y-16.63%
GM growth 3Y-3.05%
GM growth 5Y0%
F-Score5
Asset Turnover1.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | 7.39 | ||
| Debt/EBITDA | 0.96 | ||
| Cap/Depr | 75.97% | ||
| Cap/Sales | 3.73% | ||
| Interest Coverage | 2.82 | ||
| Cash Conversion | 77.2% | ||
| Profit Quality | 391.93% | ||
| Current Ratio | 1.69 | ||
| Quick Ratio | 0.97 | ||
| Altman-Z | 2.32 |
F-Score5
WACC5.45%
ROIC/WACC0.47
Cap/Depr(3y)104.36%
Cap/Depr(5y)108.93%
Cap/Sales(3y)4.28%
Cap/Sales(5y)4.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.76%
EPS 3YN/A
EPS 5Y-13.49%
EPS Q2Q%-55%
EPS Next Y-46.59%
EPS Next 2Y-15.16%
EPS Next 3Y1.74%
EPS Next 5Y2.73%
Revenue 1Y (TTM)-4.27%
Revenue growth 3Y15.7%
Revenue growth 5Y3.95%
Sales Q2Q%0.24%
Revenue Next Year-6.53%
Revenue Next 2Y-2.19%
Revenue Next 3Y-0.53%
Revenue Next 5YN/A
EBIT growth 1Y-13.44%
EBIT growth 3Y88.37%
EBIT growth 5Y-2.23%
EBIT Next Year175.1%
EBIT Next 3Y48.78%
EBIT Next 5YN/A
FCF growth 1Y147.58%
FCF growth 3Y41.02%
FCF growth 5YN/A
OCF growth 1Y363.84%
OCF growth 3Y25.56%
OCF growth 5Y38.55%